Management of Children With Persistent ITP, A Novel Approach

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

March 1, 2026

Conditions
Persistent Immune Thrombocytopenia
Interventions
BIOLOGICAL

Mini-Pool IVIG

Mini-pool intravenous immunoglobulin (IVIG) is a plasma-derived biologic prepared from small pools of locally donated human plasma using a validated, virus-inactivated, closed-system process. Each participant will receive a loading dose of 1 g/kg infused intravenously over 6-8 hours. Maintenance doses of 0.5 g/kg will be given every 2 to 4 weeks for up to five additional doses, with the dosing schedule adjusted based on platelet count. The preparation contains purified IgG and meets safety standards for sterility and viral inactivation.

Trial Locations (3)

11566

RECRUITING

Ain Shams University, Cairo

44519

RECRUITING

Zagazig University, Pediatric departement, Zagazig

71515

RECRUITING

Children's hospital - Assiut University, Asyut

All Listed Sponsors
collaborator

Zagazig University

OTHER_GOV

collaborator

Ain Shams University

OTHER

lead

Assiut University

OTHER